Abstract

Response to letter to the editor Re: comment on "Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration".

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call